Statutory Instruments
2026 No. 23
CONSUMER PROTECTION
The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026
Made
12th January 2026
Laid before Parliament
15th January 2026
Coming into force in accordance with regulation 1(2) and (3)
The Secretary of State makes these Regulations in exercise of the powers conferred by Articles 31(1)(b), 31(1)(f) and 32(1) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products(1) (“the Cosmetic Regulation”).
In accordance with Article 31(1)(b) of the Cosmetic Regulation, the Secretary of State considers there is sufficient scientific evidence that there is a potential risk to human health arising from the use of 3-(4'-methylbenzylidene)-camphor in a cosmetic product and from the current threshold for warning labelling requirements for formaldehyde releasing preservatives listed in Annex 5 to the Cosmetic Regulation.
In accordance with Article 31(1)(f) of the Cosmetic Regulation, the substances set out in the Schedule to these Regulations have been classified as CMR(2) substances of category 1B or 2 under Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures(3).
Citation, commencement, extent and interpretation
1.—(1) These Regulations may be cited as the Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026.
(2) Subject to paragraph (3), these Regulations come into force on 15th July 2026.
(3) Regulation 2(3) comes into force on 15th August 2026.
(4) These Regulations extend to England and Wales and Scotland.
(5) In these Regulations “ the Cosmetic Regulation ” means Regulation of the European Parliament and of the Council on cosmetic products. (EC) No 1223/2009
Amendments to the Cosmetic Regulation
2.—(1) The Cosmetic Regulation is amended as follows.
(2) At the end of the table in Annex 2 (list of substances prohibited in cosmetic products) insert—
| “1744 | 3-(4’-methylbenzylidene)-camphor | 38102-62-4/36861-47-9 | 253-242-6”. |
(3) In the table in Annex 2, after the entry inserted by regulation 2(2), insert the entries set out in the Schedule to these Regulations.
(4) In paragraph 2 of the Preamble to Annex 5 (list of preservatives allowed in cosmetic products)—
(a)for “contains” substitute “releases”; and
(b)for “0,05” substitute “0.001”.
(5) In the table in Annex 6 (list of UV filters allowed in cosmetic products), omit the entry at reference number 18 (3-(4-Methylbenzylidene)-d1 camphor/Enzacamene).
Transitional Provisions
3. Despite the amendments made—
(a)by regulation 2(2), (4) and (5) of these Regulations, a cosmetic product placed on the market before 15th July 2026 may continue to be made available on the market until the end of 14th January 2027 if it—
(i)contains the substance inserted into Annex 2 to the Cosmetic Regulation by regulation 2(2) and omitted from Annex 6 to the Cosmetic Regulation by regulation 2(5); and
(ii)is labelled in accordance with the requirements set out in paragraph 2 of the Preamble to Annex 5 to the Cosmetic Regulation, as it has effect before 15th July 2026;
(b)by regulation 2(3) of these Regulations, a cosmetic product placed on the market before 15th August 2026 containing any of the substances inserted into Annex 2 to the Cosmetic Regulation by regulation 2(3) may continue to be made available on the market until the end of 14th February 2027.
Kate Dearden
Parliamentary Under-Secretary of State
Department for Business and Trade
12th January 2026
Regulation 2(3)
Schedule Entries to be inserted into Annex 2
| “1745 | Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 75980-60-8 | 278-355-8 |
| 1746 | clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine | 210880-92-5 | 433-460-1 |
| 1747 | Dimethyl propylphosphonate | 18755-43-6 | 242-555-3 |
| 1748 | Dibutyltin maleate | 78-04-6 | 201-077-5 |
| 1749 | Dibutyltin oxide | 818-08-6 | 212-449-1 |
| 1750 | 2,2’, 6,6’-tetrabromo-4,4’-isopropylidenediphenol; tetrabromobisphenol-A | 79-94-7 | 201-236-9 |
| 1751 | 1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs. | 68953-84-4 | 273-227-8 |
| 1752 | 4-Methylimidazole | 822-36-6 | 212-497-3 |
| 1753 | Acetone Oxime | 127-06-0 | 204-820-1 |
| 1754 | Benthiavalicarb isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate | 177406-68-7 | |
| 1755 | 2,3-epoxypropyl neodecanoate | 26761-45-5 | 247-979-2 |
| 1756 | Multi-walled carbon tubes (synthetic graphite in tubular shape) with a geometric tube diameter range ≥ 30 nm to < 3 µm and a length ≥ 5 µm and aspect ratio > 3:1, including Multi-Walled Carbon Nanotubes, MWC(N)T | ||
| 1757 | 7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptan-3-carboxylate | 2386-87-0 | 219-207-4 |
| 1758 | 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4- (morpholin-4-yl)phenyl]butan-1-one | 119344-86-4 | 438-340-0 |
| 1759 | S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (R a S a)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methox-ypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] | 87392-12-9 | |
| 1760 | Trimethyl borate | 121-43-7 | 204-468-9” |
EUR 2009/1223; relevant amending instruments are S.I. 2022/659, S.I. 2023/836, S.I. 2024/1334, S.I. 2025/901.
For the definition of “CMR” see Article 2(1)(va) of the Cosmetic Regulation.
EUR 2008/1272, to which there are amendments not relevant to these Regulations.